Certain prostate tumors have the potential to become metastatic if not treated aggressively, according to new research from Dana-Farber Cancer Institute.

While widely touted as osteoporosis preventive must-haves, extra calcium and vitamin D in men do not appear to prevent bone thinning.

Antioxidants, substances or nutrients that can prevent or slow oxidative damage in your body, have been shown to increase fertility in men.

A new RNA therapy has been shown to prevent prostate-cancer stem cells from replicating, thanks to new research from University of Texas MD Anderson Cancer Center.

Researchers at the University of Helsinki in Finland have found that vitamin E increases life expectancy in certain groups of men aged 71 and older.

The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.

An intravenous dose of ketamine, an anesthetic, may curb depression symptoms within 40 minutes in patients with treatment-resistant bipolar disorder.

Interstitial brachytherapy may or may not hold advantages compared to other therapy options in men with localized prostate cancer, according to a new study.

The cancer drug cisplatin can be more effectively administered once encapsulated in a nanoparticle that targets prostate tumor cells and activates upon arrival.

5a-reductase inhibitors (5a-RIs), drugs that treat conditions associated with benign prostatic hyperplasia (BPH, or prostate enlargement), have been shown to produce sexual side effects in some patients.